Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction.
Girerd N, Von Hunolstein JJ, Pellicori P, Bayés-Genís A, Jaarsma T, Lund LH, Bilbault P, Boivin JM, Chouihed T, Costa J, Eicher JC, Fall E, Kenizou D, Maillier B, Nazeyrollas P, Roul G, Zannad N, Rossignol P, Seronde MF; EF-HF Group. Girerd N, et al. Among authors: pellicori p. ESC Heart Fail. 2022 Aug;9(4):2063-2069. doi: 10.1002/ehf2.13929. Epub 2022 Apr 15. ESC Heart Fail. 2022. PMID: 35429120 Free PMC article. No abstract available.
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.
Ferreira JP, Girerd N, Pellicori P, Duarte K, Girerd S, Pfeffer MA, McMurray JJ, Pitt B, Dickstein K, Jacobs L, Staessen JA, Butler J, Latini R, Masson S, Mebazaa A, Rocca HP, Delles C, Heymans S, Sattar N, Jukema JW, Cleland JG, Zannad F, Rossignol P; Heart ‘OMics’ in AGEing (HOMAGE) initiative and the High-Risk Myocardial Infarction database initiative. Ferreira JP, et al. Among authors: pellicori p. BMC Med. 2016 Nov 10;14(1):181. doi: 10.1186/s12916-016-0731-2. BMC Med. 2016. PMID: 27829460 Free PMC article. Clinical Trial.
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial.
Pellicori P, Ferreira JP, Mariottoni B, Brunner-La Rocca HP, Ahmed FZ, Verdonschot J, Collier T, Cuthbert JJ, Petutschnigg J, Mujaj B, Girerd N, González A, Clark AL, Cosmi F, Staessen JA, Heymans S, Latini R, Rossignol P, Zannad F, Cleland JGF. Pellicori P, et al. Eur J Heart Fail. 2020 Sep;22(9):1711-1723. doi: 10.1002/ejhf.1716. Epub 2020 Jan 16. Eur J Heart Fail. 2020. PMID: 31950604 Free article. Clinical Trial.
Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure.
Stienen S, Ferreira JP, Pitt B, Cleland JG, Pellicori P, Girerd N, Rossignol P, Zannad F. Stienen S, et al. Among authors: pellicori p. Eur J Heart Fail. 2020 May;22(5):901-903. doi: 10.1002/ejhf.1812. Epub 2020 Apr 3. Eur J Heart Fail. 2020. PMID: 32243646 Free article. No abstract available.
216 results